Significantly, abnormal regulation of B2R‐VEGF/VEGF‐R2 and impaired angiogenesis contributes to increased peripheral resistance and blood pressure, leading to hypertension and end‐organ damage (Humar et al., 2009), as observed in OSA. The gene discussed is VEGFA; the disease is obstructive sleep apnea syndrome.